NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/23/2021
Back to search
Official data from USPTO
TAFINLAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/23/2021
Trademark type
Word
Nice classes
5
Filing date
07/28/2010
Registration date
06/14/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/23/2021
Last transaction
04/23/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
4056 BASEL, CH
Examiner
LOOK, JEFFREY
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
NOVARTIS PHARMA AG
GLAXOSMITHKLINE LLC
Glaxo Group Limited
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcological hepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/23/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/23/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
01/11/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/14/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/27/2017
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/27/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/27/2017
ES8R
TEAS SECTION 8 RECEIVED
02/20/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/14/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/02/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/02/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/24/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/17/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/07/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/07/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/05/2012
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/05/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/23/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
06/14/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/29/2011
PUBO
PUBLISHED FOR OPPOSITION
03/29/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/24/2011
ALIE
ASSIGNED TO LIE
02/24/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/19/2011
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/19/2011
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/07/2010
GNSL
LETTER OF SUSPENSION E-MAILED
11/07/2010
CNSL
SUSPENSION LETTER WRITTEN
11/07/2010
DOCK
ASSIGNED TO EXAMINER
11/07/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2010
NWAP
NEW APPLICATION ENTERED
07/31/2010
Continuous trademark protection
Get notified about every new filing that threatens TAFINLAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.